"{\"reaction number\":1, \"description\":\"Distribution of Anti-CTLA-4 mAb between the central and lymph node compartments\"},"
"{\"reaction number\":2, \"description\":\"Distribution of Anti-CTLA-4 mAb between the central and leaky tissues\"},"
"{\"reaction number\":3, \"description\":\"Distribution of Anti-CTLA-4 mAb between the central and tight tissues\"},"
"{\"reaction number\":4, \"description\":\"Distribution of Anti-CTLA-4 mAb between the central and tumor compartments\"},"
"{\"reaction number\":5, \"description\":\"Clearance of Anti-CTLA-4 mAb from the central compartment\"},"
"{\"reaction number\":6, \"description\":\"The generation of Effector T cells and their migration into the blood/plasma from the designated number of lymph nodes as a multiple of that from a single lymph node\"},"
"{\"reaction number\":7, \"description\":\"Trafficking of free Effector T cells from blood to GI vasculature\"},"
"{\"reaction number\":8, \"description\":\"Trafficking of free Effector T cells from blood to Liver vasculature\"},"
"{\"reaction number\":9, \"description\":\"Trafficking of free Effector T cells from blood to Spleen vasculature\"},"
"{\"reaction number\":10, \"description\":\"Trafficking of free Effector T cells from blood to Lymph Node vasculature\"},"
"{\"reaction number\":11, \"description\":\"The natural turnover of Effector T cells in the blood\"},"
"{\"reaction number\":12, \"description\":\"Trafficking of free Effector T cells from blood to Peripheral (other tissues not directly accounted for) vasculature\"},"
"{\"reaction number\":13, \"description\":\"Trafficking of free Effector T cells from blood to Tumor vasculature\"},"
"{\"reaction number\":14, \"description\":\"Distribution of Anti-PD-1 mAb between the central and lymph node compartments\"},"
"{\"reaction number\":15, \"description\":\"Distribution of Anti-PD-1 mAb between the central and leaky tissues\"},"
"{\"reaction number\":16, \"description\":\"Distribution of Anti-PD-1 mAb between the central and tight tissues\"},"
"{\"reaction number\":17, \"description\":\"Distribution of Anti-PD-1 mAb between the central and tumor compartments\"},"
"{\"reaction number\":18, \"description\":\"Clearance of Anti-PD-1 mAb from the central compartment\"},"
"{\"reaction number\":19, \"description\":\"Distribution of Anti-PD-L1 mAb between the central and lymph node compartments\"},"
"{\"reaction number\":20, \"description\":\"Distribution of Anti-PD-L1 mAb between the central and leaky tissues\"},"
"{\"reaction number\":21, \"description\":\"Distribution of Anti-PD-L1 mAb between the central and tight tissues\"},"
"{\"reaction number\":22, \"description\":\"Distribution of Anti-PD-L1 mAb between the central and tumor compartments\"},"
"{\"reaction number\":23, \"description\":\"Clearance of Anti-PD-L1 mAb from the central compartment\"},"
"{\"reaction number\":24, \"description\":\"Saturation of Anti-PD-L1 mAb clearance from the central compartment\"},"
"{\"reaction number\":25, \"description\":\"Trafficking of Effector T cells from GI to Liver vasculature\"},"
"{\"reaction number\":26, \"description\":\"Turnover of free Effector T cells in the GI vasculature\"},"
"{\"reaction number\":27, \"description\":\"Extravasation of arrested Effector T cells from the Liver vasculature\"},"
"{\"reaction number\":28, \"description\":\"Turnover of arrested Effector T cells in the Liver vasculature\"},"
"{\"reaction number\":29, \"description\":\"Arrest of bound Effector T cells in the Liver vasculature\"},"
"{\"reaction number\":30, \"description\":\"Detachment of bound Effector T cells in the Liver vasculature\"}"
"{\"reaction number\":31, \"description\":\"Turnover of bound Effector T cells in the liver vasculature\"},"
"{\"reaction number\":32, \"description\":\"Trafficking of free Effector T cells from Liver to Lung vasculature\"},"
"{\"reaction number\":33, \"description\":\"Turnover of free Effector T cells in the liver vasculature\"},"
"{\"reaction number\":34, \"description\":\"Trafficking of free Effector T cells from Liver to lymph node extravascular space\"},"
"{\"reaction number\":35, \"description\":\"Turnover of Effector T cells in the Liver extravascular space\"},"
"{\"reaction number\":36, \"description\":\"Extravasation of arrested Effector T cells from the Spleen vasculature\"},"
"{\"reaction number\":37, \"description\":\"Turnover of arrested Effector T cells in the Spleen vasculature\"},"
"{\"reaction number\":38, \"description\":\"Arrest of bound Effector T cells in the Spleen vasculature\"},"
"{\"reaction number\":39, \"description\":\"Detachment of bound Effector T cells in the Spleen vasculature\"},"
"{\"reaction number\":40, \"description\":\"Turnover of bound Effector T cells in the Spleen vasculature\"},"
"{\"reaction number\":41, \"description\":\"Binding or free Effector T cells to the Spleen vasculature\"},"
"{\"reaction number\":42, \"description\":\"Trafficking of free Effector T cells from Spleen to Liver vasculature\"},"
"{\"reaction number\":43, \"description\":\"Turnover of free Effector T cells in the Spleen vasculature\"},"
"{\"reaction number\":44, \"description\":\"Trafficking of free Effector T cells from Spleen to lymph node extravascular space\"},"
"{\"reaction number\":45, \"description\":\"Turnover of Effector T cells in the Spleen extravascular space\"},"
"{\"reaction number\":46, \"description\":\"Binding or free Effector T cells to the Liver vasculature\"},"
"{\"reaction number\":47, \"description\":\"Extravasation of arrested Effector T cells from the Lungs vasculature\"},"
"{\"reaction number\":48, \"description\":\"Turnover of arrested Effector T cells in the Lungs vasculature\"},"
"{\"reaction number\":49, \"description\":\"Depletion of arrested Effector T cells in the Lungs vasculature\"},"
"{\"reaction number\":50, \"description\":\"Binding or free Effector T cells to the Lungs vasculature\"},"
"{\"reaction number\":51, \"description\":\"Trafficking of free Effector T cells from Lungs to (arterial) Blood\"},"
"{\"reaction number\":52, \"description\":\"Turnover of free Effector T cells in the Lungs vasculature\"},"
"{\"reaction number\":53, \"description\":\"Trafficking of free Effector T cells from Lungs to lymph node extravascular space\"},"
"{\"reaction number\":54, \"description\":\"Turnover of Effector T cells in the Lungs extravascular space\"},"
"{\"reaction number\":55, \"description\":\"Arrest of bound Effector T cells in the Lungs vasculature\"},"
"{\"reaction number\":56, \"description\":\"Detachment of bound Effector T cells in the Lungs vasculature\"},"
"{\"reaction number\":57, \"description\":\"Turnover of bound Effector T cells in the Lungs vasculature\"},"
"{\"reaction number\":58, \"description\":\"Depletion of bound Effector T cells in the Lungs vasculature\"},"
"{\"reaction number\":59, \"description\":\"Interaction at the immunological synapse between CD80 on Primed Naive T cells and PD-L1 on T Regulatory cells in the lymph node\"},"
"{\"reaction number\":60, \"description\":\"CD80 expression threshold on Primed Naive T cells for interaction with T Regulatory cells in the lymph node\"}"
"{\"reaction number\":61, \"description\":\"Interaction at the immunological synapse between PD-1 on Primed Naive T cells and PD-L1 on T Regulatory cells in the lymph node\"},"
"{\"reaction number\":62, \"description\":\"Interaction at the immunological synapse between PD-1 on Primed Naive T cells and Anti-PD-1 mAb in the lymph node\"},"
"{\"reaction number\":63, \"description\":\"PD-1 expression threshold on Primed Naive T cells for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\":64, \"description\":\"Interaction at the immunological synapse between PD-L1 on Primed Naive T cells and Anti-PD-L1 mAb in the lymph node\"},"
"{\"reaction number\":65, \"description\":\"PD-L1 expression threshold on Primed Naive T cells for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\":66, \"description\":\"Inactivation of Na\u00efve T cells by T Regulatory cells in the lymph node\"},"
"{\"reaction number\":67, \"description\":\"Dissociation of T Regulatory cells from Na\u00efve T cells in the lymph node without inactivation of the latter\"},"
"{\"reaction number\":68, \"description\":\"Inactivation of Primed Na\u00efve T cells by T Regulatory cells in the lymph node\"},"
"{\"reaction number\":69, \"description\":\"Dissociation of T Regulatory cells from Primed Na\u00efve T cells in the lymph node without inactivation of the latter\"},"
"{\"reaction number\":70, \"description\":\"CD80 expression by Primed Naive T cells for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\":71, \"description\":\"PD-1 expression by Primed Naive T cells for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\":72, \"description\":\"PD-L1 expression by Primed Naive T cells for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\":73, \"description\":\"PD-1 expression by T Regulatory cells for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":74, \"description\":\"PD-L1 expression by T Regulatory cells for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":75, \"description\":\"CD80 expression threshold on mAPCs for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\":76, \"description\":\"CD86 expression threshold on mAPCs for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\":77, \"description\":\"Interaction at the immunological synapse between CD80 on mAPCs and CTLA-4 on T Regulatory cells in the lymph node\"},"
"{\"reaction number\":78, \"description\":\"Interaction at the immunological synapse between CD86 on mAPCs and CTLA-4 on T Regulatory cells in the lymph node\"},"
"{\"reaction number\":79, \"description\":\"Interaction at the immunological synapse between CTLA-4 on T Regulatory cells and Anti-CTLA-4 mAb in the lymph node\"},"
"{\"reaction number\":80, \"description\":\"CTLA-4 expression threshold on T Regulatory cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\":81, \"description\":\"Interaction at the immunological synapse between PD-L1 on Primed Naive T cells and PD-1 on T Regulatory cells in the lymph node\"},"
"{\"reaction number\":82, \"description\":\"Interaction at the immunological synapse between PD-1 on T Regulatory cells and Anti-PD-1 mAb in the lymph node\"},"
"{\"reaction number\":83, \"description\":\"PD-1 expression threshold on Regulatory cells for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":84, \"description\":\"Interaction at the immunological synapse between PD-L1 on T Regulatory cells and Anti-PD-L1 mAb in the lymph node\"},"
"{\"reaction number\":85, \"description\":\"Interaction at the immunological synapse between PD-L1 on T Regulatory cells and Anti-PD-1 mAb in the lymph node\"},"
"{\"reaction number\":86, \"description\":\"Phagocytosis of tumor debris by resident APCs in the lymph node\"},"
"{\"reaction number\":87, \"description\":\"Decay of tumor debris in the lymph nodes\"},"
"{\"reaction number\":88, \"description\":\"Lymph return of Anti-CTLA-4 to the blood\"},"
"{\"reaction number\":89, \"description\":\"Interaction at the immunological synapse between CTLA-4 on Primed Na\u00efve T cells during priming interactions with mAPCS and Anti-CTLA-4 mAb in the lymph node\"},"
"{\"reaction number\":90, \"description\":\"Internalization of the CTLA-4 receptor on Primed Na\u00efve T cells following its binding to Anti-CTLA-4 mAb\"}"
"{\"reaction number\":91, \"description\":\"Migration of Effector T cells from the lymph node into the blood (removal linked to regeneration by algebraic equation below)\"},"
"{\"reaction number\":92, \"description\":\"Return of Effector T cells from lymph node extravascular space to the Lungs vascular space\"},"
"{\"reaction number\":93, \"description\":\"Turnover of Effector T cells in the lymph node extravascular space\"},"
"{\"reaction number\":94, \"description\":\"Trafficking of free Effector T cells from lymph node vascular space to the Lungs vascular space\"},"
"{\"reaction number\":95, \"description\":\"Turnover of free Effector T cells in the lymph node vascular space\"},"
"{\"reaction number\":96, \"description\":\"CD80 expression by total mAPCs in the lymph node\"},"
"{\"reaction number\":97, \"description\":\"CD86 expression by total mAPCs in the lymph node\"},"
"{\"reaction number\":98, \"description\":\"PD-1 expression by total mAPCs in the lymph node\"},"
"{\"reaction number\":99, \"description\":\"PD-L1 expression by total mAPCs in the lymph node\"},"
"{\"reaction number\":100, \"description\":\"PD-L2 expression by total mAPCs in the lymph node\"},"
"{\"reaction number\":101, \"description\":\"Natural turnover of mAPCs in the lymph node\"},"
"{\"reaction number\":102, \"description\":\"Inactivation of mAPCs in the lymph node as a result of CTLA-4 secreted from T Regulatory cells in the lymph nodes binding to CD80 and CD86\"},"
"{\"reaction number\":103, \"description\":\"CD80 expression threshold on mAPCs in the lymph node\"},"
"{\"reaction number\":104, \"description\":\"CD86 expression threshold on mAPCs in the lymph node\"},"
"{\"reaction number\":105, \"description\":\"CD80 expression by mAPCs that interact with Naive T cells in the lymph node\"},"
"{\"reaction number\":106, \"description\":\"CD86 expression by mAPCs that interact with Naive T cells in the lymph node\"},"
"{\"reaction number\":107, \"description\":\"CD80 expression threshold on mAPCs for interaction with Naive T cells in the lymph node\"},"
"{\"reaction number\":108, \"description\":\"CD86 expression threshold on mAPCs for interaction with Naive T cells in the lymph node\"},"
"{\"reaction number\":109, \"description\":\"CD80 expression by mAPCs that interact with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":110, \"description\":\"CD86 expression by mAPCs that interact with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":111, \"description\":\"PD-1 expression by mAPCs that interact with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":112, \"description\":\"PD-L1 expression by mAPCs that interact with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":113, \"description\":\"PD-L2 expression by mAPCs that interact with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":114, \"description\":\"Interaction at the immunological synapse between CD80 on mAPCs and CTLA-4 on Primed Na\u00efve T cells in the lymph node\"},"
"{\"reaction number\":115, \"description\":\"Interaction at the immunological synapse between CD80 on mAPCs and PD-L1 on Primed Na\u00efve T cells in the lymph node\"},"
"{\"reaction number\":116, \"description\":\"CD80 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":117, \"description\":\"Interaction at the immunological synapse between CD86 on mAPCs and CTLA-4 on Primed Na\u00efve T cells in the lymph node\"},"
"{\"reaction number\":118, \"description\":\"Interaction at the immunological synapse between CD86 on mAPCs and CD28 on Primed Na\u00efve T cells in the lymph node\"},"
"{\"reaction number\":119, \"description\":\"CD86 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\":120, \"description\":\"Interaction at the immunological synapse between PD-1 on mAPCs cells during priming interactions with Primed Na\u00efve T cells and Anti-PD-1 mAb in the lymph node\"}"
"{\"reaction number\": 121, \"description\": \"PD-1 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 122, \"description\": \"PD-L1 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 123, \"description\": \"Interaction at the immunological synapse between PD-L2 on mAPCs and PD-1 on Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 124, \"description\": \"PD-L2 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 125, \"description\": \"PD-1 expression threshold on total mAPCs in the lymph node\"},"
"{\"reaction number\": 126, \"description\": \"PD-L1 expression threshold on total mAPCs in the lymph node\"},"
"{\"reaction number\": 127, \"description\": \"PD-L2 expression threshold on total mAPCs in the lymph node\"},"
"{\"reaction number\": 128, \"description\": \"Engagement of Naive T cells in the first priming phase in the lymph node\"},"
"{\"reaction number\": 129, \"description\": \"Naive T cells cycling out of the lymph node\"},"
"{\"reaction number\": 130, \"description\": \"Naive T cells being disengaged in the first priming phase without undergoing successful priming in the lymph node\"},"
"{\"reaction number\": 131, \"description\": \"Naive T cells successfully undergoing the first priming phase in the lymph node\"},"
"{\"reaction number\": 132, \"description\": \"Transendocytosis of the CD80 receptors on mAPCs through CTLA-4 binding and internalization on Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 133, \"description\": \"Transendocytosis of the CD86 receptors on mAPCs through CTLA-4 binding and internalization on Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 134, \"description\": \"Interaction at the immunological synapse between CD80 on mAPCs cells and CD28 on Naive T cells in the lymph node\"},"
"{\"reaction number\": 135, \"description\": \"Interaction at the immunological synapse between CD86 on mAPCs cells and CD28 on Naive T cells in the lymph node\"},"
"{\"reaction number\": 136, \"description\": \"CD28 expression threshold on Naive T cells in the lymph node\"},"
"{\"reaction number\": 137, \"description\": \"Naive T cells expressing CD28 in the lymph node\"},"
"{\"reaction number\": 138, \"description\": \"Lymph return of Anti-PD-1 to the blood\"},"
"{\"reaction number\": 139, \"description\": \"Lymph return of Anti-PD-L1 to the blood\"},"
"{\"reaction number\": 140, \"description\": \"Interaction at the immunological synapse between PD-L1 on mAPCs involved in the second priming phase and Anti-PD-L1 mAb in the lymph node\"},"
"{\"reaction number\": 141, \"description\": \"Interaction at the immunological synapse between PD-L1 on Primed Naive T cells involved in the second priming phase with mAPCs and Anti-PD-L1 mAb in the lymph node\"},"
"{\"reaction number\": 142, \"description\": \"CTLA-4 expression threshold on Primed Naive T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 143, \"description\": \"Interaction at the immunological synapse between CD80 on mAPCs and CD28 on Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 144, \"description\": \"CD28 expression threshold on Primed Naive T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 145, \"description\": \"Interaction at the immunological synapse between PD-L1 on mAPCs and CD80 on Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 146, \"description\": \"CD80 expression threshold on Primed Naive T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 147, \"description\": \"Interaction at the immunological synapse between PD-L1 on mAPCs and PD-1 on Primed Naive T cells in the lymph node\"},"
"{\"reaction number\": 148, \"description\": \"Interaction at the immunological synapse between PD-1 on Primed Naive T cells involved in the second priming phase with mAPCs and Anti-PD-1 mAb in the lymph node\"},"
"{\"reaction number\": 149, \"description\": \"PD-1 expression threshold on Primed Naive T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 150, \"description\": \"Interaction at the immunological synapse between PD-1 on mAPCs and PD-L1 on Primed Naive T cells in the lymph node\"}"
"{\"reaction number\": 151, \"description\": \"PD-L1 expression threshold on Primed Na\u00efve T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 152, \"description\": \"CTLA-4 expression by Primed Na\u00efve T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 153, \"description\": \"CD28 expression by Primed Na\u00efve T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 154, \"description\": \"CD80 expression by Primed Na\u00efve T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 155, \"description\": \"PD-1 expression by Primed Na\u00efve T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 156, \"description\": \"PD-L1 expression by Primed Na\u00efve T cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 157, \"description\": \"Primed Na\u00efve T cells engaging in the second priming phase in the lymph node\"},"
"{\"reaction number\": 158, \"description\": \"Primed Na\u00efve T cells unsuccessfully undergoing the second priming phase to become anergic T cells in the lymph node\"},"
"{\"reaction number\": 159, \"description\": \"Primed Na\u00efve T cells engaged in the second priming phase disengaging form being primed in the lymph node\"},"
"{\"reaction number\": 160, \"description\": \"Primed Na\u00efve T cells engaged in the second priming phase successfully undergoing priming to become Proliferating T cells in the lymph node\"},"
"{\"reaction number\": 161, \"description\": \"Proliferating T cells becoming fully activated Effector T cells in the lymph node\"},"
"{\"reaction number\": 162, \"description\": \"Sets the proliferation threshold for Proliferating T cells in the lymph node\"},"
"{\"reaction number\": 163, \"description\": \"Internalization of the Anti-CTLA-4 antibodies bound to CTLA-4 receptors on T Regulatory cells in the lymph node\"},"
"{\"reaction number\": 164, \"description\": \"Transendocytosis of the CD80 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the lymph node\"},"
"{\"reaction number\": 165, \"description\": \"Transendocytosis of the CD86 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the lymph node\"},"
"{\"reaction number\": 166, \"description\": \"CTLA-4 expression on the surface of non-interacting T Regulatory cells in the lymph node\"},"
"{\"reaction number\": 167, \"description\": \"Interaction between T Regulatory cells and mAPCs in lymph node\"},"
"{\"reaction number\": 168, \"description\": \"Interaction between T Regulatory cells and Na\u00efve T cells in lymph node\"},"
"{\"reaction number\": 169, \"description\": \"Interaction between T Regulatory cells and Primed Na\u00efve T cells in lymph node\"},"
"{\"reaction number\": 170, \"description\": \"Dissociation of T Regulatory cells from mAPCs in the lymph node with inactivation of the latter\"},"
"{\"reaction number\": 171, \"description\": \"Dissociation of T Regulatory cells from mAPCs in the lymph node without inactivation of the latter\"},"
"{\"reaction number\": 172, \"description\": \"CD80 expression by mAPCs for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\": 173, \"description\": \"CD86 expression by mAPCs for interaction with T Regulatory cells in the lymph node\"},"
"{\"reaction number\": 174, \"description\": \"CTLA-4 expression by T Regulatory cells for interaction with mAPCs in the lymph node\"},"
"{\"reaction number\": 175, \"description\": \"Binding of Anti-CTLA-4 to CTLA-4 expressed on the surface of non-interacting T Regulatory in the lymph node\"},"
"{\"reaction number\": 176, \"description\": \"CTLA-4 expression threshold on non-interacting T Regulatory cells in the lymph node\"},"
"{\"reaction number\": 177, \"description\": \"Administration of Anti-CTLA-4 mAb into the central compartment\"},"
"{\"reaction number\": 178, \"description\": \"Administration of Anti-PD-1 mAb into the central compartment\"},"
"{\"reaction number\": 179, \"description\": \"Administration of Anti-PD-L1 mAb into the central compartment\"},"
"{\"reaction number\": 180, \"description\": \"Na\u00efve T cells cycling into the lymph node\"}"
"{\"reaction number\":181, \"description\":\"The proliferation rate of the Proliferating T cells in the lymph node\"},"
"{\"reaction number\":182, \"description\":\"Appearance of monocytes in the tumor\"},"
"{\"reaction number\":183, \"description\":\"Proliferation of cancer cells in the tumor\"},"
"{\"reaction number\":184, \"description\":\"Distribution of Anti-CTLA-4 mAb between leaky tissues and lymph node\"},"
"{\"reaction number\":185, \"description\":\"Distribution of Anti-CTLA-4 mAb between tight tissues and lymph node\"},"
"{\"reaction number\":186, \"description\":\"Trafficking of free Effector T cells from Peripheral tissues vasculature to the lung vasculature\"},"
"{\"reaction number\":187, \"description\":\"Turnover of free Effector T cells in the Peripheral tissues vasculature\"},"
"{\"reaction number\":188, \"description\":\"Distribution of Anti-PD-1 mAb between leaky tissues and lymph node\"},"
"{\"reaction number\":189, \"description\":\"Distribution of Anti-PD-1 mAb between tight tissues and lymph node\"},"
"{\"reaction number\":190, \"description\":\"Distribution of Anti-PD-L1 mAb between leaky tissues and lymph node\"},"
"{\"reaction number\":191, \"description\":\"Distribution of Anti-PD-L1 mAb between tight tissues and lymph node\"},"
"{\"reaction number\":192, \"description\":\"CD80 expression by the T5 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":193, \"description\":\"PD-1 expression by the T2 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":194, \"description\":\"PD-1 expression by the T9 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":195, \"description\":\"CD80 expression by the T9 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":196, \"description\":\"PD-1 expression by the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":197, \"description\":\"PD-L1 expression by the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":198, \"description\":\"PD-1 expression by the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":199, \"description\":\"PD-L1 expression by the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":200, \"description\":\"CD80 expression by the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":201, \"description\":\"PD-1 expression by the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":202, \"description\":\"PD-L1 expression by the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":203, \"description\":\"PD-L2 expression by the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":204, \"description\":\"PD-1 expression by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":205, \"description\":\"PD-L1 expression by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":206, \"description\":\"PD-L2 expression by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":207, \"description\":\"CD80 expression by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":208, \"description\":\"PD-1 expression by the T7 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":209, \"description\":\"PD-L2 expression by the T7 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":210, \"description\":\"PD-1 expression by the T15 subtype of cancer cells in the tumor\"}"
"{\"reaction number\":211, \"description\":\"PD-L2 expression by the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":212, \"description\":\"CD80 expression by the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":213, \"description\":\"PD-L1 expression by the T3 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":214, \"description\":\"PD-L1 expression by the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":215, \"description\":\"CD80 expression by the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":216, \"description\":\"PD-L1 expression by the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":217, \"description\":\"PD-L2 expression by the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":218, \"description\":\"PD-L1 expression by the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":219, \"description\":\"PD-L2 expression by the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":220, \"description\":\"CD80 expression by the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":221, \"description\":\"PD-L2 expression by the T4 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":222, \"description\":\"PD-L2 expression by the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":223, \"description\":\"CD80 expression by the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":224, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T10 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":225, \"description\":\"PD-1 expression threshold by the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":226, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T10 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":227, \"description\":\"PD-L1 expression threshold by the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":228, \"description\":\"PD-L2 expression threshold by the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":229, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T11 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":230, \"description\":\"PD-L1 expression threshold by the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":231, \"description\":\"CD80 expression threshold by the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":232, \"description\":\"PD-L2 expression threshold by the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":233, \"description\":\"CD80 expression threshold by the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":234, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T13 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":235, \"description\":\"PD-L1 expression threshold by the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":236, \"description\":\"PD-L2 expression threshold by the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":237, \"description\":\"CD80 expression by the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":238, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T14 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":239, \"description\":\"PD-1 expression threshold by the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":240, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T14 subtype of cancer cells and CD80 on the complementary Effector T cells in the tumor\"}"
"{\"reaction number\":241, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T14 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":242, \"description\":\"PD-L1 expression threshold by the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":243, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the T14 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":244, \"description\":\"CD80 expression threshold by the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":245, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T15 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":246, \"description\":\"PD-1 expression threshold by the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":247, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T15 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":248, \"description\":\"PD-L2 expression threshold by the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":249, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the T15 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":250, \"description\":\"CD80 expression threshold by the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":251, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T16 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":252, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T16 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":253, \"description\":\"PD-1 expression threshold by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":254, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T16 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":255, \"description\":\"PD-L1 expression threshold by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":256, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T16 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":257, \"description\":\"PD-L2 expression threshold by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":258, \"description\":\"CD80 expression threshold by the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":259, \"description\":\"PD-1 expression threshold by the T2 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":260, \"description\":\"PD-L1 expression threshold by the T3 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":261, \"description\":\"PD-L2 expression threshold by the T4 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":262, \"description\":\"CD80 expression threshold by the T5 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":263, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T6 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":264, \"description\":\"PD-1 expression threshold by the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":265, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T6 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":266, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T6 subtype of cancer cells and CD80 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":267, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T6 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":268, \"description\":\"PD-L1 expression threshold by the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":269, \"description\":\"PD-1 expression threshold by the T7 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":270, \"description\":\"PD-L2 expression threshold by the T7 subtype of cancer cells in the tumor\"}"
"{\"reaction number\":271, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T8 subtype of cancer cells and CD80 on Effector T cells in the tumor\"},"
"{\"reaction number\":272, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T8 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":273, \"description\":\"PD-L1 expression threshold by the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":274, \"description\":\"PD-L2 expression threshold by the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":275, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T9 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":276, \"description\":\"PD-1 expression threshold by the T9 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":277, \"description\":\"CD80 expression threshold by the T9 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":278, \"description\":\"Transendocytosis of the CD80 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the tumor\"},"
"{\"reaction number\":279, \"description\":\"Transendocytosis of the CD86 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the tumor\"},"
"{\"reaction number\":280, \"description\":\"Internalization of the Anti-CTLA-4 antibodies bound to CTLA-4 receptors on T Regulatory cells in the tumor\"},"
"{\"reaction number\":281, \"description\":\"PD-1 expression by Effector T cells interacting with the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":282, \"description\":\"CD80 expression by Effector T cells interacting with the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":283, \"description\":\"PD-1 expression by Effector T cells interacting with the T3 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":284, \"description\":\"CD80 expression by Effector T cells interacting with the T3 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":285, \"description\":\"PD-L1 expression by Effector T cells interacting with the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":286, \"description\":\"PD-1 expression by Effector T cells interacting with the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":287, \"description\":\"CD80 expression by Effector T cells interacting with the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":288, \"description\":\"PD-L1 expression by Effector T cells interacting with the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":289, \"description\":\"PD-1 expression by Effector T cells interacting with the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":290, \"description\":\"CD80 expression by Effector T cells interacting with the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":291, \"description\":\"PD-L1 expression by Effector T cells interacting with the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":292, \"description\":\"PD-1 expression by Effector T cells interacting with the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":293, \"description\":\"CD80 expression by Effector T cells interacting with the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":294, \"description\":\"PD-L1 expression by Effector T cells interacting with the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":295, \"description\":\"PD-1 expression by Effector T cells interacting with the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":296, \"description\":\"CD80 expression by Effector T cells interacting with the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":297, \"description\":\"PD-L1 expression by Effector T cells interacting with the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":298, \"description\":\"PD-1 expression by Effector T cells interacting with the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":299, \"description\":\"PD-L1 expression by Effector T cells interacting with the T7 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":300, \"description\":\"PD-1 expression by Effector T cells interacting with the T7 subtype of cancer cells in the tumor\"}"
"{\"reaction number\":301, \"description\":\"PD-L1 expression by Effector T cells interacting with the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":302, \"description\":\"PD-1 expression by Effector T cells interacting with the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":303, \"description\":\"PD-L1 expression by Effector T cells interacting with the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":304, \"description\":\"PD-1 expression by Effector T cells interacting with the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":305, \"description\":\"PD-L1 expression by Effector T cells interacting with the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":306, \"description\":\"PD-1 expression by Effector T cells interacting with the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":307, \"description\":\"PD-1 expression by Effector T cells interacting with the T4 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":308, \"description\":\"PD-L1 expression by Effector T cells interacting with the T9 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":309, \"description\":\"PD-L1 expression by Effector T cells interacting with the T5 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":310, \"description\":\"PD-L1 expression by Effector T cells interacting with the T2 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":311, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T10 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":312, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T10 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":313, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":314, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T10 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":315, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T10 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":316, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":317, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T10 subtype of cancer cells and CD80 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":318, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the T10 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":319, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T11 subtype of cancer cells and CD80 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":320, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T11 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":321, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":322, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T11 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":323, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T11 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":324, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the T12 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":325, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T12 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":326, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":327, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T12 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":328, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T12 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":329, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the T13 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":330, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T13 subtype of cancer cells in the tumor\"}"
"{\"reaction number\":331, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T13 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":332, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T13 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":333, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T13 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":334, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T13 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":335, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T14 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":336, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":337, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T14 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":338, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":339, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the T14 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":340, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T15 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":341, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T15 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":342, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":343, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T15 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":344, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T15 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":345, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the T16 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":346, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T16 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":347, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":348, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T16 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":349, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T16 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":350, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":351, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T16 subtype of cancer cells and CD80 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":352, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the T16 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":353, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T2 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":354, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T2 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":355, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T3 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":356, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T3 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":357, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T3 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":358, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T3 subtype of cancer cells and CD80 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":359, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the T3 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":360, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T4 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"}"
"{\"reaction number\":361, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T4 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":362, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T4 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":363, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the T5 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":364, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T5 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":365, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T5 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":366, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T6 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":367, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T6 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":368, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":369, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T6 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":370, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":371, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the T6 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":372, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T7 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":373, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T7 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":374, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T7 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":375, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T7 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":376, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T8 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":377, \"description\":\"Interaction at the immunological synapse between PD-L2 expressed by the T8 subtype of cancer cells and PD-1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":378, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":379, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the T8 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":380, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the T9 subtype of cancer cells and PD-L1 on the complementary Effector T cells in the tumor\"},"
"{\"reaction number\":381, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T9 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":382, \"description\":\"PD-L1 expression threshold by the Effector T cells interacting with the T9 subtype of cancer cells in the tumor\"},"
"{\"reaction number\":383, \"description\":\"Turnover of resting macrophages\"},"
"{\"reaction number\":384, \"description\":\"Phagocytosis of tumor debris by resting APCs in the lymph node\"},"
"{\"reaction number\":385, \"description\":\"Transport of tumor debris from the tumor to the lymph node\"},"
"{\"reaction number\":386, \"description\":\"Decay of tumor debris in the tumor\"},"
"{\"reaction number\":387, \"description\":\"The distribution of tumor debris away from any of the considered lymph nodes\"},"
"{\"reaction number\":388, \"description\":\"Accounting for the distribution of tumor debris from the tumor to the lymph nodes other than the lymph node compartment in the model\"},"
"{\"reaction number\":389, \"description\":\"Natural turnover of cancer cells in the tumor\"},"
"{\"reaction number\":390, \"description\":\"CD80 expression threshold by the mAPCs interacting with the T Regulatory cells in the tumor\"}"
"{\"reaction number\":391, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the Effector T cells and PD-L1 on the T Regulatory cells in the tumor\"},"
"{\"reaction number\":392, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the T Regulatory cells in the tumor\"},"
"{\"reaction number\":393, \"description\":\"CD80 expression threshold by the Effector T cells interacting with the MDSCs in the tumor\"},"
"{\"reaction number\":394, \"description\":\"CD86 expression threshold by the mAPCs interacting with the T Regulatory cells in the tumor\"},"
"{\"reaction number\":395, \"description\":\"Flow of Anti-CTLA-4 mAb between the tumor and lymph node\"},"
"{\"reaction number\":396, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the mAPCs and CTLA-4 on the T Regulatory cells in the tumor\"},"
"{\"reaction number\":397, \"description\":\"Interaction at the immunological synapse between CD86 expressed by the mAPCs and CTLA-4 on the T Regulatory cells in the tumor\"},"
"{\"reaction number\":398, \"description\":\"Interaction at the immunological synapse between CTLA-4 expressed by the T Regulatory cells and Anti-CTLA-4 in the tumor\"},"
"{\"reaction number\":399, \"description\":\"CTLA-4 expression threshold by the T Regulatory cells interacting with the mAPCs in the tumor\"},"
"{\"reaction number\":400, \"description\":\"Turnover of Effector T cells in the tumor\"},"
"{\"reaction number\":401, \"description\":\"Apoptosis of Effector T cells following complete cancer cell death in the tumor\"},"
"{\"reaction number\":402, \"description\":\"Conversion of Effector T cells into Resident Effector Memory cells following complete cancer cell death in the tumor\"},"
"{\"reaction number\":403, \"description\":\"Association of Effector T cells with cancer cells in the tumor\"},"
"{\"reaction number\":404, \"description\":\"Turnover of arrested Effector T cells in Tumor vasculature\"},"
"{\"reaction number\":405, \"description\":\"Extravasation of arrested Effector T cells into Tumor interstitium\"},"
"{\"reaction number\":406, \"description\":\"Turnover of bound Effector T cells in Tumor vasculature\"},"
"{\"reaction number\":407, \"description\":\"Arrest of bound Effector T cells in the Tumor vasculature\"},"
"{\"reaction number\":408, \"description\":\"Detachment of bound Effector T cells in the Tumor vasculature\"},"
"{\"reaction number\":409, \"description\":\"Binding or free Effector T cells to the Tumor vasculature\"},"
"{\"reaction number\":410, \"description\":\"Trafficking of free Effector T cells from the Tumor vasculature to the Lungs vasculature\"},"
"{\"reaction number\":411, \"description\":\"Turnover of free Effector T cells in Tumor vasculature\"},"
"{\"reaction number\":412, \"description\":\"Transport of mAPCs from the tumor to the lymph node\"},"
"{\"reaction number\":413, \"description\":\"Accounting for the distribution of mAPCs from the tumor to the lymph nodes other than the lymph node compartment in the model\"},"
"{\"reaction number\":414, \"description\":\"The distribution of mAPCs away from any of the considered lymph nodes\"},"
"{\"reaction number\":415, \"description\":\"CD80 expression by mAPCs interacting with the T Regulatory cells in the tumor\"},"
"{\"reaction number\":416, \"description\":\"CD86 expression by mAPCs interacting with the T Regulatory cells in the tumor\"},"
"{\"reaction number\":417, \"description\":\"Association of Effector T cells with MDSCs in the tumor\"},"
"{\"reaction number\":418, \"description\":\"PD-1 expression by MDSCs interacting with the Effector T cells in the tumor\"},"
"{\"reaction number\":419, \"description\":\"PD-L1 expression by MDSCs interacting with the Effector T cells in the tumor\"},"
"{\"reaction number\":420, \"description\":\"Dissociation of MDSCs from Effector T cells with inactivation of the latter in the tumor\"}"
"{\"reaction number\":421, \"description\":\"Dissociation of MDSCs from Effector T cells without inactivation of the latter in the tumor\"},"
"{\"reaction number\":422, \"description\":\"Distribution of Anti-PD-1 mAb between Tumor and Lymph Node\"},"
"{\"reaction number\":423, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T14 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":424, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T2 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":425, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T7 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":426, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T9 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":427, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T10 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":428, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T11 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":429, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T12 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":430, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T14 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":431, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T7 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":432, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T8 subtype of cancer cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":433, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T Regulatory cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":434, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the MDSCs interacting with Effector T cells and Anti- PD-1 in the tumor\"},"
"{\"reaction number\":435, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells and PD-1 on the MDSCs in the tumor\"},"
"{\"reaction number\":436, \"description\":\"PD-1 expression threshold by the MDSCs interacting with the Effector T cells in the tumor\"},"
"{\"reaction number\":437, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells and PD-L1 on the T Regulatory cells in the tumor\"},"
"{\"reaction number\":438, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the T Regulatory cells in the tumor\"},"
"{\"reaction number\":439, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the MDSCs and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":440, \"description\":\"PD-1 expression threshold by the Effector T cells interacting with the MDSCs in the tumor\"},"
"{\"reaction number\":441, \"description\":\"Interaction at the immunological synapse between PD-1 expressed by the T Regulatory cells interacting with the Effector T cells and Anti-PD-1 in the tumor\"},"
"{\"reaction number\":442, \"description\":\"PD-1 expression threshold by the T Regulatory cells interacting with the Effector T cells in the tumor\"},"
"{\"reaction number\":443, \"description\":\"Distribution of Anti-PD-L1 mAb between Tumor and Lymph Node\"},"
"{\"reaction number\":444, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the T3 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":445, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T13 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":446, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T2 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":447, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T7 subtype of cancer cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":448, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T Regulatory cells and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":417, \"description\":\"Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the MDSCs and Anti-PD-L1 in the tumor\"},"
"{\"reaction number\":418, \"description\":\"Interaction at the immunological synapse between CD80 expressed by the Effector T cells and PD-L1 on the MDSCs in the tumor\"}"